Cite
HARVARD Citation
Jin, Y. et al. (2018). Beneficial effects of Rifaximin in post‐infectious irritable bowel syndrome mouse model beyond gut microbiota. Journal of gastroenterology and hepatology. 33 (2), pp. 443-452. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jin, Y. et al. (2018). Beneficial effects of Rifaximin in post‐infectious irritable bowel syndrome mouse model beyond gut microbiota. Journal of gastroenterology and hepatology. 33 (2), pp. 443-452. [Online].